ABSTRACT BACKGROUND Leukaemias are characterised by abnormal proliferation of haematopoietic cells, causing progressive infiltration of the marrow. It is the eleventh most common cancer in the world, and increasingly found now. Two widely used classifications are currently used, the FAB, and the WHO classification, which has got supplanted now, with increasing knowledge on cytomorphology and cytogenetics. This study attempts to evaluate the role of cytochemistry in various types of leukaemias, as well as the role of immunophenotyping in a select few cases, which were referred to the Department of Pathology, at Thanjavur Medical College. We wanted to study, the types and subtypes of leukaemias using cytochemistry, their morphology, the demographic distribution and their clinical and haematological presentation.
affected. Leukaemia is the ninth commonest cancer in the world, and is the ninth most common in males, which is 3% of total cancers in them, and is eleventh most common in females, 2% of total cancers in them.
Age standardized rates for Asian males range from 6.3 to 10.6 per 100, 000. In India the number of new cases were 13 per 100, 000 men and women per year. Generally males are affected more than females. 1, 2, 3 Two widely used classifications are used, one by the French, American, and British group called the FAB Classification, and other by the World Health Organisation (WHO Classification), based on the morphologic findings, genetic abnormalities, clinical and Immunophenotyping characteristics. 3, 2, 5 Overall annual incidence in the general population is 4 per 100, 000, with approximately 70% being Acute myeloid leukaemia (AML). AML accounts for about 90% of the acute leukaemias in adult population and 15% of the cases in childhood leukaemias. Acute lymphoblastic leukaemia (ALL) is primarily a childhood disease and commonly seen at a peak age of 2 or 3 years. Chronic myeloid leukaemia (CML) occurs typically between ages 40 and 60, and the Chronic lymphoid leukaemia (CLL) occur most after 65 years of age. This study attempts to evaluate the role of cytochemistry in classifying the various types of Leukaemia and its subtypes, by a combination of morphology on the peripheral blood smear, as well as correlate with the clinical and haematological findings of the cases, with available means in our laboratory. Cytomorphological assessment, based on FAB Classification was made, Immunophenotyping, was done for a select few cases, where there was doubt, or ambiguity, and its concordance with the cytochemical staining patterns and findings were taken into account. 1, 6, 4, 7 Peripheral blood smear, suspected of leukaemia, in cases received at the Department of pathology, Thanjavur Medical College, was taken during the period from January 2015 to June 2016, and studied for this purpose. The study also aims to tell that the simple and cost-effective method of cytochemical stains, are a valuable tool, in aiding the diagnostic methods in leukaemia. 
METHODS

Study Design
Observational study. The present study had a sample size of 56 cases of leukaemia, diagnosed in the department of pathology, Thanjavur medical college. Sample size was taken based on the convenience of study. Those cases referred to the department of pathology, with clinical suspicion, were subjected to peripheral smear study by standard Romanowsky stains first, mainly by Leishman's stain and a presumptive diagnosis was made. Following which peripheral blood smears were subjected to special cytochemical stains using Sudan Black B (SBB) and Periodic acid Schiff's reagent stain(PAS). 7, 8, 9, 10, 11 The percentage of blast cells were enumerated, and the cytomorphology studied based on their positive staining effects on the respective blood smears, were noted. Thereby the types and subtypes of leukaemias were classified and reported as per FAB Classification. 1, 4, 3 Inclusion Criteria Peripheral blood smear from all cases of all age groups who presented with clinical features and abnormal haematological values suggestive of leukaemia.
Exclusion Criteria
Nil.
Statistical Analysis
The collected data was entered in Microsoft excel, and analysed using statistical package for social sciences (SPSS 18.0) software. One-way ANOVA was used to test the significance of clinico-haematological parameters. The cases were in the range of 1 to 93 years. Table. 1, shows the age distribution, with the majority of the percentage lying in the age group 11 to 20 years, and 31 to 40 years, each having 12 cases in the category, which was found to be 21%. This was followed by the age group less than 10 years, with 10 cases, which was 18%, and 41 to 50 years group with 8 cases having 14%, closely followed by the 21 to 30 years group, with 7 cases, amounting to 12%. The total Male cases in AML, was 10 in number, and Females were 14, accounting to 42% and 58% respectively. The total Male cases in ALL, were 8, and females were 4, with a 67% and 33% respectively. Chronic Neutrophilic leukaemia (CNL) 1 6
RESULTS
The
Sex
Types and Subtypes of Leukaemia
Juvenile CML 1 6 CLL (n=3) 3 100 Table 3 .
Distribution of Patients According to Types and Sub-Types of Leukaemia
This table depicts the distributive nature of the different types and subtypes of leukaemia. Of the total 56 cases, AML, with 24 cases (43%), was the highest, followed by CML with 17 cases (30%), ALL with 12 cases (22%) and CLL with 3 cases (5%), was the least. In AML, 13 cases were of M2 (55%), followed by M1, which had 6 cases (25%). In ALL, 6 cases were seen, each in L1 and L2, 50% equally distributed. CML, had 9 cases (52%) in the chronic phase, which was highest, with 3 each in accelerated phase (18%) and blast crisis (18%). One case of Juvenile CML, and another case of CNL, was also seen.
Hb in Gram %
ALL
AML CML CLL Nos. % Nos. % Nos. % Nos. % < 6
10 83% 17 71% 6 35% 1 34% 6.1 -9 1 9% 6 25% 6 35% 1 33% 9.1 -12 1 8% 1 4% 4 24% 1 33% 12 and above 0 0% 0 0% 1 6% 0 0%
Table 4. Haemoglobin Distribution Among the Cases
Haemoglobin was seen to be less, and anaemia more prevalent in acute leukaemias than the chronic ones. ALL had as high as 83% cases with below 6 gm/dl values, followed by AML which had 71% cases. CML and CLL had 35% and 34% respectively. 3 25% 0 0% 0 0% 1 33% 4001-11000 0 0% 3 12% 0 0% 2 67% 11001 -50000 4 33% 11 46% 3 18% 0 0% 50001 -100000 3 25% 6 25% 4 24% 0 0% 100001 -200000 2 17% 4 17% 5 29% 0 0% > 200000 0 0% 0 0% 5 29% 0 0% Table 5 .
Total Leukocyte Count in Cases
The total leukocyte count showed higher values of up to 50, 000/µl, in 46% of AML cases, and up to 100, 000/µl in 25% of them. ALL showed 33% and 25% in the same value range. Both AML and ALL, had 33% cases with a total count value up to 200, 000/µl. CML, had 29% cases of total count values, up to and with more than 200, 000/µl. CLL, by and large had a normal range of total count value between 4000 to 11, 000/µl in 67% of the cases. 33% of CLL, and 25% of ALL, had a total count value less than 4000/µl. Platelet counts were seen less than 50, 000/cumm, in 75% of AML, and in 71% of ALL cases. CML, had 76% cases, with more than 100, 000/cumm, whereas 24% had less than 50, 000/cumm. CLL had 34% cases, up to the value of 100.000/cumm, and more than 150, 000/cumm in 33% cases. Table 7 . Different Haematological Parameters According to The Types of Leukaemia Table 7 provides the different statistics for the haematological parameters according the types of leukaemia. The maximum mean haemoglobin level was observed in CLL, followed by CML, AML and ALL, the least. The mean Total count, was maximum in CML, followed by ALL, AML and CLL. The mean platelet count, was high in CML, followed by CLL, ALL, and least in AML. Using One-way ANOVA, by SPSS, the significance analysis of the differences in the group means, resulted into a p value of < 0.0001, and indicated, it was highly significant across the leukaemia types. With regards to haemoglobin, the highest mean levels were seen with cases having lymphadenopathy, and the lowest in cases with splenomegaly. The difference in mean Hb levels by one-way ANOVA, resulted in a p value of 0.52. In the case of total count, the highest value was observed in patients with splenomegaly, and the least was seen in cases with hepatomegaly, the p value obtained, was 0.54. And with platelet count, the highest mean values obtained were in patients with lymphadenopathy, followed by hepatomegaly and the least in splenomegaly. The p value obtained here was 0.51. There were no statistically significant differences, between the group means, and the clinical features, as determined by one-way ANOVA.
Signs
Distribution of acute cases of leukaemia as per cytochemistry. Out of 56 cases in total, 36 cases were acute, AML was 24, which was 67%, and ALL was 12, at 33%, for the cytochemical staining with both SBB, and PAS. Immunophenotyping Results 6 cases underwent flow cytometry, using peripheral blood samples, with 2 cases using regular AML panel and 3 cases with ALL panel, and with one CML case with its panel, for cases suspected and doubtful. Though they showed cytochemical stain positive, the results were obtained, with the plots on the side scatter graph. 4 cases were concordant with the cytochemical stained smear diagnosis. But 2 cases of ALL, were partially concordant, and were requiring bone marrow aspirate samples for flow cytometry. Flow concordance percentage was 67%, and the remaining 33% was not in concordance, for peripheral blood sample-1. AML M2 showed CD 13, CD, 33, CD, 117 positivity 2. AML M1 showed CD 13, CD 33 positivity 3. ALL L1 showed CALLA positivity with CD10 gated blasts. 4. ALL L2 showed mild blasts but required a bone marrow aspirate analysis. 5. CML showed CD117, CD13, CD33, CD34 positivity in the gated blasts. 6. ALL L1 showed lymphocytosis, required a bone marrow aspirate analysis.
Cytochemistry
DISCUSSION
Leukaemias, as such are now common, and affects all ages and genders. It requires a multi-parameter approach for its diagnosis, which includes cytomorphology study, with phenotypic and genotypic studies. In the present study 56 cases, were evaluated, by studying their morphology using cytochemical stains, as well as clinical features, and with 6 cases for concordant Immunophenotyping, using lineage specific panels with markers. 1, 12, 13, 14, 15 Of the 56 cases, 36 cases were acute leukaemias (64%), of which 24 were AML (43%), and 12 were ALL (22%). The rest 20 cases were chronic cases (36%), of which 17 were CML (30%), which include one case of chronic neutrophilic leukaemia, and 3 were CLL cases (5%). This clearly shows acute leukaemias, being more common than chronic ones. In the acute group, AML was more common than ALL, and in the chronic group CML was commoner than CLL. After subtyping of acute leukaemias with cytochemistry, the study showed in AML, 2 cases of M0 (8%), 6 cases of M1 (25%), 13 cases of M2 (55%), 1 case of M3 (4%), 2 cases of M4 (8%). No cases of M5, M6 and M7 were detected. This showed that AML M2 was the commonest, in the FAB classification, and AML showed higher predominance than ALL or CML. However, CML cases were found to be second commonest, this could be due to population bias, and its limitations in the study. Gender distribution showed a female preponderance of leukaemias as a whole in the study of the 56 cases. Males were of 48% and females 52%. This again reflects the nature of swing in the population, though generally it is commoner in males. 16 AML had a higher female preponderance of 58%, against 42% in males, and it showed the same pattern in CML and CLL too, whereas ALL had more males showing 67% and females 33%. Age distribution clearly shows ALL, predominantly in the children and early adolescence group, and ranges to about 92% of the cases, followed by AML with 42%. CML was more common, in the 21 to 40 age group, and CLL had 33% in the above 40 age group. Haemoglobin values were less than 6 gm% in 83% of ALL cases, and 71% in AML cases. 35% of CML cases, and 34% of CLL cases, had less than 6 gm%, this clearly indicates, severe anaemia as a co-existing disorder, in cases of acute leukaemia. Total count values, were seen in high ranges in CML, with more than 100, 000/µl, in 58% of cases, and as much as 29% of them had more than 200, 000/µl, followed by AML, which had 46% of cases up to 50, 000/µl, and 25% more than that. ALL had 33% up to 50, 000/µl, and 25% in more than that. CLL had 67% of cases up to 11, 000/µl, and 33% less than 4000/µl. This signifies that elevated counts will have less mature cells, and more of the immature variety. Leucopenia is an uncommon feature. 1, 6 Platelet counts in general are lower in acute leukaemias, and normal to higher or rarely lower in Chronic leukaemias. This was interpreted in the study, and ALL had 75% cases with lesser values below 50, 000/cumm, and AML had 71% cases, below that level. CML had normal to higher values of more than 150, 000/cumm in 76% of their cases. CLL had more than 66% of their cases with more than 100, 000/cumm. This signifies that acute leukaemias, end up with less production of platelets, with decreased survival, causing thrombocytopenia. CML, usually has normal ranges in the chronic phase, but in the blast phase, they fall below the normal range just like in the acute cases. A thrombocytopenic picture in CML, always signals that an accelerated phase has started its process, leading to blast crisis. 1 ANOVA analysis showed the p value to be statistically significant across the group of means of the laboratory values, in the haematological parameters. A clear picture of the haematological values in assessing the Total count, Platelet count and Haemoglobin is essential in the diagnostic aid of leukaemias. Various clinical presentations are seen in leukaemias, assessment of splenomegaly, hepatomegaly and lymphadenopathy, were taken into account in this study. Splenomegaly was the commonest feature seen in 21 cases, followed by hepatomegaly in 16 cases, and 7 cases had lymphadenopathy. One particular feature seen here was a lesser platelet count, a lower haemoglobin value, and a total count less than 50.000/µl, in cases which had splenomegaly. There were no statistically significant differences, between the haematological value group means and the clinical features, as obtained by one-way ANOVA. Varying nature of clinical features were seen. CML invariably had splenomegaly in all their cases; and hepatomegaly was randomly seen in AML, as well as CML and ALL. CLL cases, all had lymphadenopathy. One case of AML M3 had disseminated intravascular coagulopathy, and one other case of CML in chronic phase, had visual disturbances. It is important to note that, in this study, the resources were limited, and costeffective measures had to be undertaken for the diagnosis. In a country like ours, where sophisticated laboratories having flow cytometric analysis for immunophenotyping, are limited in number, are a costly affair. Hence, here a select few cases, were taken to undergo Flow cytometric analysis. Six cases were taken into account. The main purpose was to see their concordance, with cytochemistry. 4 cases were concordant with the flow cytometric analysis, one ALL, one CML, and two AML cases were found to be concordant, with cytochemical findings, the other two ALL cases required a bone marrow aspirate, and secondary markers for the lineage identity, which as per our study was out of our limitations. 67% were concordant, and effective in diagnosing the cases in our study. Flow analysis uses a viable single cell suspension for the method, this consideration is important to note that haemodiluting effects can alter the analytical process, and can result in differences in results. Quality control and maintenance of equipment is highly essential, which should be scrupulously followed. By and large, a practical method, in our setting would be to do a basic peripheral blood smear with routine stains, and with cytochemistry and morphology, a diagnosis can be made. In case of ambiguity or lineage specific identification, for the follow up of therapy and prognosis, flow cytometric analysis and cytogenetics would be of immense help.
Leukaemias are a heterogenous group of disorders, having varied clinical, morphological, molecular cytogenetic characteristics, and have prognostic and therapeutic implications on identifying them correctly. In our study, predominance of myeloid neoplasms was found, and AML was the commonest type noted as per the statistical data. ALL was more common in the childhood category, and AML was more common in the adults' group, closely followed by CML. The gender distribution showed a slight raise in female preponderance as a whole, but Male predominance was seen in ALL type, with AML and CML having a slight female preponderance. Anaemia, as determined by haemoglobin values, was more severe in acute leukaemias, especially in ALL and AML, whereas it was mild to moderate in the chronic types. Leucocytosis was more in CML, and AML, as well as in ALL, than in CLL, depicting the clonal proliferation of cells. Thrombocytopenia was more in acute leukaemias, than in the chronic types, affirming the criteria for evaluation. Clinical features like splenomegaly were commonly present in CML; hepatomegaly was evenly distributed; lymphadenopathy was seen mostly in CLL. Cytochemical stains used were profoundly positive, in almost all cases, except in one case of chronic neutrophilic leukaemia. Acute leukaemias were well studied, with the stains, SBB and PAS, and accurately classified as per FAB classification.
CONCLUSIONS
A leukaemia diagnosis protocol is the need of the hour considering the economics involved. In a setting where there is a lack of facilities for flow cytometry, as in majority of centres in the developing countries, morphology combined with cytochemistry, still serves as the best means in diagnosing leukaemia cases.
Current therapeutics and prognostic factors rely more on flow cytometry and cytogenetics, and the WHO has classified leukaemias on its basis. This has prompted a new beginning in identification of the types and morphology. Hence a simpler adaptive format, with cost effective means can be devised in countries, where there are very few or no facilities.
